Concepedia

Lucinda Shaw

LS

3

Publications

2.3K

Citations

3

H-Index

2005

Active since

Affiliations

Mirna Therapeutics (United States)(Current)

Lucinda Shaw is an author at Mirna Therapeutics (United States) specializing in hepatitis, viral hepatitis, and medicinal chemistry.

Top concepts

Publications per year

2005–2018

3

Publications

3

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs

Jennifer A. Lockridge, Lucinda Shaw, Karin S. Blanchard et al. · Nature Biotechnology · 2005 · 1.2K citations

, , +9

A Single Administration of CRISPR/Cas9 Lipid Nanoparticles Achieves Robust and Persistent In Vivo Genome Editing

Jonathan D. Finn, Amy Smith, Mihir Patel et al. · Cell Reports · 2018 · 801 citations · Full text

Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication†

Karin S. Blanchard, Lucinda Shaw, Kristi Jensen et al. · Hepatology · 2005 · 290 citations · Full text

Rows per page

1–3 of 3